We are live on ! Find out more
US Bancorp

US Bancorp Portfolio holdings

AUM $82.4B
1-Year Est. Return 19.69%
This Fund
S&P 500
This Quarter Est. Return
+7.07%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$53.4B
AUM Growth
+$3.95B
Cap. Flow
+$662M
Cap. Flow %
1.24%
Top 10 Hldgs %
27.71%
Holding
4,164
New
242
Increased
1,490
Reduced
1,373
Closed
118

Sector Composition

Rank Sector Weight
1 Technology 13.08%
2 Financials 9.18%
3 Healthcare 8.48%
4 Industrials 7.72%
5 Consumer Staples 5.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
3576
PUT
Procter & Gamble
PG
$343B
$6K ﹤0.01%
37
-10
-21% -$1.35K
PGEN icon
3577
Precigen
PGEN
$1.93B
$6K ﹤0.01%
862
-200
-19% -$1.4K
QABA icon
3578
First Trust NASDAQ ABA Community Bank Index Fund
QABA
$92.1M
$6K ﹤0.01%
100
RSPG icon
3579
Invesco S&P 500 Equal Weight Energy ETF
RSPG
$572M
$6K ﹤0.01%
125
SA
3580
Seabridge Gold
SA
$2.8B
$6K ﹤0.01%
314
-76
-19% -$1.37K
ECHO
3581
EchoStar
ECHO
$25.5B
$6K ﹤0.01%
229
+42
+22% +$1.08K
SJB icon
3582
ProShares Short High Yield
SJB
$52.1M
$6K ﹤0.01%
330
XHR
3583
Xenia Hotels & Resorts
XHR
$1.98B
$6K ﹤0.01%
326
-117
-26% -$2.25K
YYY icon
3584
Amplify CEF High Income ETF
YYY
$716M
$6K ﹤0.01%
355
SLCA
3585
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$6K ﹤0.01%
551
+165
+43% +$1.91K
CDAK
3586
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$6K ﹤0.01%
+300
New +$5.76K
ATCO
3587
DELISTED
Atlas Corp.
ATCO
$6K ﹤0.01%
427
-474
-53% -$6.58K
BLPH
3588
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$6K ﹤0.01%
1,221
ACRE
3589
Ares Commercial Real Estate
ACRE
$252M
$5K ﹤0.01%
338
ADAP
3590
DELISTED
Adaptimmune Therapeutics
ADAP
$5K ﹤0.01%
1,139
-188
-14% -$912
AEVA
3591
Aeva Technologies
AEVA
$1.02B
$5K ﹤0.01%
100
AFRM icon
3592
Affirm
AFRM
$23.5B
$5K ﹤0.01%
+74
New +$4.72K
AGQ icon
3593
ProShares Ultra Silver
AGQ
$1.16B
$5K ﹤0.01%
100
ALEX
3594
DELISTED
Alexander & Baldwin
ALEX
$5K ﹤0.01%
298
ALLK
3595
DELISTED
Allakos
ALLK
$5K ﹤0.01%
59
-4
-6% -$400
AMRX icon
3596
Amneal Pharmaceuticals
AMRX
$5.72B
$5K ﹤0.01%
1,073
-368
-26% -$2.09K
BBIO icon
3597
BridgeBio Pharma
BBIO
$16.5B
$5K ﹤0.01%
81
+43
+113% +$2.46K
CLDT
3598
Chatham Lodging
CLDT
$630M
$5K ﹤0.01%
391
CTBI icon
3599
Community Trust Bancorp
CTBI
$1.38B
$5K ﹤0.01%
123
EBMT icon
3600
Eagle Bancorp Montana
EBMT
$186M
$5K ﹤0.01%
211

Similar funds

US Bancorp's Q2 2021 Portfolio in Review

As of Q2 2021, US Bancorp held 4,164 positions worth $53.4B, up 8% from $49.4B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

US Bancorp's Q2 2021 filing shows 242 new, 1,490 increased, 1,373 reduced and 118 closed positions. Its largest new stake was Organon & Co: 165,056 shares worth $5M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $28M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • US Bancorp's largest Q2 2021 buy was Organon & Co: 165,056 shares worth $5M.
  • US Bancorp added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $110M increase.
  • US Bancorp's biggest Q2 2021 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $28M.
  • US Bancorp fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $6.31M.
  • US Bancorp's ten largest holdings make up 28% of its $53.4B portfolio in Q2 2021.
  • US Bancorp opened 242 new positions and closed 118 in Q2 2021.
  • US Bancorp's portfolio value rose 8% quarter-over-quarter to $53.4B.

Based on US Bancorp's 13F filing for Q2 2021, filed 5 Aug 2021.